The Top Penny Stocks newsletter for active penny stocks investors looking for penny stocks and pink sheet stocks
Richemont chairman Johann Rupert to take 'grey gap... Billionaire 62-year-old to take 12 months off from Cartier and Montblanc luxury goods groupRichemont's chairman and founder Johann Rupert is to take a year off from September, leaving management of the...
Cambodia: aftermath of fatal shoe factory collapse... Workers clear rubble following the collapse of a shoe factory in Kampong Speu, Cambodia, on Thursday
Spate of recent shock departures by 50-something CEOs While the rising financial rewards of running a modern multinational have been well publicised, executive recruiters say the pressures of the job have also been ratcheted upOn approaching his 60th birthday...
UK Uncut loses legal challenge over Goldman Sachs tax... While judge agreed the deal was 'not a glorious episode in the history of the Revenue', he ruled it was not unlawfulCampaign group UK Uncut Legal Action has lost its high court challenge over the legality...
Eurozone crisis live: Japan's strong growth figures... PM Shinzo Abe's stimulus package could generate feelgood factor needed to end two decades of stagnant growthPhillip Inman
Category : World News
Notable earnings before Thursday’s open: ABC, AET, AMLN, AUO, AZN, BC, BG, BLLL, BMY, BWA, CAM, CCE, CELG, CL, CMS, CNX, D, DB, DDD, DNKN, DOW, ELN, EQT, ETR, FIS, GR, GTI, HOT, HP, INCY, IPG, IRM, IVZ, JBLU, K, LINE, LIZ, LLL, LMT, MCO, MJN, MO, MWW, MYL, NBL, NIHD, OCR, ORI, OXY, PCS ,PDS, PEP, PHM, POT, PTEN, RTN, SHPGY, SWC, SWI, SWY, TLAB, TS, TSM, TWC, TYC, UAL, UPS, VNTV, WHR, WM, XEL, XOM, YNDX, ZMH 
Post your comment!
NEW YORK (TheStreet) — Watson Pharmaceuticals has bought Actavis for roughly $5.6 billion, paying $1 billion less for the Swiss generic drug maker than initial M&A rumors had suggested.
The merger will make Watson Pharmaceuticals the world’s third largest generics drugs maker with a combined revenue of $8 billion, while increasing its international presence. In unveiling the deal, Watson also said that a combination of synergies and growth opportunities will make the merger additive to earnings in coming years.
“Actavis dramatically enhances our commercial position on a global basis and brings complementary products and capabilities in the United States,” said Watson Pharmaceuticals CEO Paul M. Bisaro, in a statement. “In a single, commercially compelling transaction, we more than double Watson’s international access and strengthen our commercial position in key established European markets as well as exciting emerging growth markets, including Central and Eastern Europe and Russia.”
…
Click to view a price quote on WPI.
Click to research the Drugs industry.More: Watson Pharma Gets Actavis at ‘Generics’ Price
Category : Stocks, World News
Mylan (MYL -2.1%) sues the FDA seeking relief over the 180-day exclusivity granted by the agency to Teva Pharmaceuticals (TEVA +0.4%) over its generic Provigil. Attorneys repping the firm filed the suit at double-speed with the launch of the narcolepsy-fighting drug just crossing the wires less than a week ago. Post your comment!
NEW YORK (TheStreet) — Gannett and Mosaic were among the best-performing stocks in the S&P 500 on Wednesday.
Both stocks are rated buy at TheStreet Ratings.
Gannett and Mosaic are among the best-performers of the S&P 500 midday Wednesday.
The S&P 500 fell 4.55 points, or 0.33%, to 1,357.66 on Wednesday.
…
Click to view a price quote on MOS.
Click to research the Chemicals industry.Read the original: Gannett, Mosaic: S&P 500 Gainers